Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bacterial ribosome 50S subunit peptidyl transferase center (PTC) is the highly conserved catalytic core of the large ribosomal subunit responsible for synthesizing proteins in bacteria. It functions as a ribozyme, where the 23S ribosomal RNA (rRNA) catalyzes the formation of peptide bonds between the growing polypeptide chain and incoming amino acids (Steitz & Moore, 2003). The PTC is situated at the junction of the ribosomal A- and P-sites and is adjacent to the nascent peptide exit tunnel (NPET). Because of its essentiality for bacterial viability, the PTC is the target for several major classes of antibiotics, including macrolides, oxazolidinones, and lincosamides (Polikanov et al., 2015). These drugs typically bind to the 23S rRNA to physically obstruct the catalytic process or the movement of the nascent peptide. While these therapies are generally selective, the structural similarity between the bacterial PTC and the human mitochondrial ribosome can lead to off-target effects such as bone marrow suppression or lactic acidosis (StatPearls, 2023). Resistance to these drugs often arises through mutations in the 23S rRNA or enzymatic modification of the binding site, such as methylation by Cfr or Erm enzymes (Wilson, 2014).
Inhibition of bacterial protein synthesis by binding to the 23S rRNA within the 50S subunit, which sterically hinders the positioning of aminoacyl-tRNA or blocks the nascent peptide exit tunnel (Wilson, 2014).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial ribosome 50S subunit peptidyl transferase center (PTC).